Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jul;48(7):583-7.
doi: 10.1590/1414-431X20154557. Epub 2015 May 26.

Evaluation of a father and son with atypical chronic myeloid leukemia with SETBP1 mutations and a review of the literature

L Wang  1 , F Du  2 , H-M Zhang  1 , H-X Wang  1
Affiliations
Review

Evaluation of a father and son with atypical chronic myeloid leukemia with SETBP1 mutations and a review of the literature

L Wang et al. Braz J Med Biol Res. 2015 Jul.

Abstract

We report the case of a father and son diagnosed with atypical chronic myeloid leukemia (aCML). Both patients harbored SETBP1 mutations, which are present in 24.3% of aCML patients. Moreover, both shared the variant encoding p.Pro737His, but the aCML severity was greater in the son because of the presence of two other missense mutations causing p.Asp868Asn and p.Ser885Arg alterations. SETBP1 mutations may be associated with an adverse prognosis, so their detection would help in the diagnosis of aCML and the determination of a patient's prognosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Bone marrow smear and biopsy of the son. A, Bone marrow smear stained with Wright-Giemsa (original magnification, 1000×). Black arrow: myeloblast (July 2013). B, Bone marrow biopsy stained with hematoxylin and eosin (original magnification, 100×). White arrow: fibroblast proliferation (July 2013).
Figure 2
Figure 2. SETBP1 mutations (boxed) present in the son (A-C) and the father (D). Upper rows indicate normal sequences, and lower rows indicate patient sequences.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937–951. doi: 10.1182/blood-2009-03-209262. - DOI - PubMed
    1. Piazza R, Valletta S, Winkelmann N, Redaelli S, Spinelli R, Pirola A, et al. Recurrent SETBP1 mutations in atypical chronic myeloid leukemia. Nat Genet. 2013;45:18–24. doi: 10.1038/ng.2495. - DOI - PMC - PubMed
    1. Maxson JE, Gotlib J, Pollyea DA, Fleischman AG, Agarwal A, Eide CA, et al. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. N Engl J Med. 2013;368:1781–1790. doi: 10.1056/nejmoa1214514. - DOI - PMC - PubMed
    1. Pardanani A, Lasho TL, Laborde RR, Elliott M, Hanson CA, Knudson RA, et al. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia. Leukemia. 2013;27:1870–1873. doi: 10.1038/leu.2013.122. - DOI - PMC - PubMed
    1. Elliott MA, Tefferi A. Chronic neutrophilic leukemia 2014: Update on diagnosis, molecular genetics, and management. Am J Hematol. 2014;89:651–658. doi: 10.1002/ajh.23667. - DOI - PubMed